GI Pharm Flashcards
Goal of HBV treatment
Suppress HBV DNA to undetectable levels
Seroconversion of HBeAg from (+) to (-)
Reduction in elevated liver transaminase levels
Goal of HCV treatment
- Viral Eradication –> Sustained viral response (absence of detectable viremia for 6mo after therapy) –> decr risk of HCC & cirrhosis
Current Tx strategy of HCV infection
Weekly administration of INF-a AND daily Ribavirin
MoA of INF-a
SC/IM/IV admin
Induces JAK-STAT pw
–> nuclear translocation of cell protein complex that binds genes w/INF-specific response element
–> induces expression of viral resistance genes
—–inh of viral penetration,etc
—–incr expression of MHC ag, incr phagocyte activity of Macrophages
Interferon Tx of HBV infection
INF a-2B
PegINF a-2A
Interferon tx of HCV infx
All 4 (INF a-2B, a-con-1; PegINF a-2A, a-2B)
Treatment of Condylomata acuminate
Genital warts caused by papilloma virus
Tx: INF a-2B
A/E of IFN-a tx
Flu-like syndrome
Alopecia
Mood disorder/depression/suicide
Adefovir MOA & TU
adenine analog– phosphorylated x2
Competitively Inhibits HBV reverse transcriptase –> chain termination
Reduces HBV DNA levels by 99% (BUT slow & least likely to induce HBeAg seroconversion)
Adefovir A/E
Nephrotoxicity
Lactic acidosis
Hepatomegaly w/steatosis
HBV exacerbation
Entecavir Pharm, MOA & T/U
Guanosine nucleoside analog
100% oral bioavailability on empty stomach
Competitively inhibits all 3 fx of HBV-RT (base priming, reverse transcrip of neg strand from pregenomic RNA, synth of + strand of HBV DNA)
For CHRONIC HBV infection w/active replication & persisten elevations in serum aminotransferase
Resistance is rare
Lamivudine- pharm, MOA, T/U, A/E
3x phosphorylated, oral
Inhibits HIV & HBV-RT enzymes by competing w/deoxycytidine triphosphate for incorp into viral DNA (-> chain term)
HBV, HIV-1, & HIV-2 infx in adults & children
A/E: pancreatitis in pts with BOTH HIV & HBV infx. Mitochondrial toxicity + lactic acidosis
What anti-Hepatitis drug are you MOST likely to see resistance with?
Telbivudine (25% after 2 years)
Telbivudine:
MOA
T/U
A/E
Thymidine nucleoside analog
Competitively inhibits HBV-RT
Chronic HBV in adults
A/E: BLACK BOX for HBV exacerbation after discontinuation, lactic acidosis, severe hepatomegaly
High resistance
Ribavirin:
MOA
T/U
A/E
Purine nucleoside analog w/D-RIBOSE sugar.
Higher oral BA w/fatty meals, lower w/antacids
Unclear MOA– may interfere w/GTP & viral RNA-dep Pol synthesis
T/U: HCV infection (in combo w/INF-a)
Also, RSV (aerosol), Lassa Fever, Viral Hemm Fevers, Measles pneumonitis, Encephalitides
A/E: ALWAYS GIVE w/IFN-a to protect from HEMOLYTIC ANEMIA
Teratogenic!!! (partner can’t take either)
Telaprevir & Boceprevir
MOA
T/U
Target viral proteases NS3A, NS4A
For HCV genotype 1 infection (only for previously untreated or previous IFN-a/Ribavirin tx failure)
— still ALWAYS use in combo with IFN-a & Ribavirin!!!
What are the subclasses of Laxatives?
- Bulk Forming
- Stool Softeners
- Osmotic
- Stimulants (Cathartics)
- Chloride channel activators
- Opioid Receptor Antagonists
Bulk forming laxatives: MOA
- Methylcellulose
- Psyllium
MOA: absorption of water –> emollient gel, causes distension of colon, promoting peristalsis
Stool softeners: MoA
- Docusate
- Mineral Oil
↓ surface tension → permits water & lipids to penetrate stool
(mineral oil aslo lubricates stool, retarding water-absorption)
Docusate is oral AND rectal; mineral oil oral only
Mineral oil A/E
Aspiration can cause severe lipid pneumonitis; impaired fat-sol vitamin absorption
Lactulose: MoA
Osmotic laxative– soluble but non-absorbable → obligate ↑ fecal fluid
*pt must maintain adequate hydration to compensate for fluid loss
Balanced Polyethylene Glycol: T/U
Osmotic laxative used for complete colonic cleansing before GI endoscopic procedures
Small doses taken to treat/prevent chronic constipation
Stimulant/Cathartic Laxatives: MOA, T/U, A/E
- Senna (natural plant)
- Bisacodyl
not sure, but may DIRECTLY STIMULATE ENS & colonic electrolyte/fluid secretion
T/U: constipation; colonic cleansing for colonoscopy (Bisacodyl)
A/E: Cathartic Colon (n. damage due to abuse); Melanosis coli (brown pigmentation- w/Senna)
Chloride Channel Activator: Lubiprostone
MOA: Stimulates type 2 Cl- channel (CLC-2) in small intestine
→ ↑ Cl-rich fluid secretion into intestine → stim intestinal motility, shorten intestinal transit time
T/U: IBS w/predominant constipation
A/E: N&V
C/I: pregnancy
Opiod Receptor Antagonists:
- Alvimopan (oral)
- Methylnaltrexone (SC)
Peripheral mu-opiod receptor antagonist
T/U:
Alvimopan: shorten period of post-operative ileus (don’t take for >7days)
Methylnatrexone: opioid-induced constipation
A/E: Alvimopan → cardiotoxicity– only given in hospital
**no analgesia effect on CNS
Use of Antidiarrheal Agents
mild-moderate acute diarrhea, diarrhea caused by IBS or IBD
DON’T use in: blood diarrhea, high fever, systemic toxicity, worsening diarrhea despite tx